價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2024-11-15 |
中文名稱:阿妥昔珠單抗 | 英文名稱:Research Grade Azintuxizumab (DHJ64002) |
CAS:1826819-57-1 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Research Grade Azintuxizumab (DHJ64002) | 靶點: SLAMF7, CRACC |
宿主: Chimeric/Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Azintuxizumab (DHJ64002) |
Catalog No.
DHJ64002
Host species
Chimeric/Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q9NQ25
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
ABBV-383, PR-1471272, ABBV-838, CAS: 1826819-57-1
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥30000 |
VIP5年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2024-11-13 | |
¥4100 |
VIP3年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2024-11-14 | |
詢價 |
VIP16年
|
上海佰世凱化學(xué)科技有限公司
|
2024-10-28 |